Page last updated: 2024-09-05

sorafenib and oleic acid

sorafenib has been researched along with oleic acid in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(oleic acid)
Trials
(oleic acid)
Recent Studies (post-2010) (oleic acid)
6,5207305,2518,7682483,051

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)oleic acid (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)6.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, R; Kuang, S; Liu, G; Peng, Q; Sun, C; Wang, J1

Other Studies

1 other study(ies) available for sorafenib and oleic acid

ArticleYear
Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:9

    Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Activation; Fatty Acids, Monounsaturated; Humans; Lipidomics; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Oleic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Sorafenib; Stearoyl-CoA Desaturase; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2019